Clinical Trials Logo

Clinical Trial Summary

The SafeBoosC-III 2 year follow up study will follow up on all patients randomised in the SafeBoosC-III clinical trial (NCT03770741). The investigators will collect data when the patients are two years of corrected age from routine standardised follow up assessments, parental questionnaires as well as informal assessments. The study will commence in September 2021, and will expect to include all 72 sites across 18 countries, which take part of the SafeBoosC-III clinical trial.


Clinical Trial Description

In the SafeBoosC-III trial, the objective is to investigate the effect of treatment based on cerebral near-infrared spectroscopy (NIRS) monitoring of brain oxygenation compared with treatment as usual in extremely preterm infants. The primary outcome of the trial is death or survival with severe brain injury at 36 weeks' postmenstrual age. Despite an association between severe brain injury diagnosed in the neonatal period and later neurodevelopmental disability, this relationship is not always strong. Therefore, if treatment based on cerebral NIRS monitoring decreases the risks of death or survival with severe brain injury, it is important to document if the beneficial effect persists into early childhood, in the form of better neurodevelopmental outcome. Furthermore, it is also important to identify evidence of unexpected harms. It would be unfortunate if cerebral NIRS monitoring became standard practice without good evidence that long-term patient-relevant benefits outweigh possible harms. As the SafeBoosC-III trial intends to randomise 1600 infants, there is potential to achieve sufficient power for a meaningful assessment of the experimental intervention's effect on long-term neurodevelopment, as well as an evaluation of unexpected harms. The objective of the SafeBoosC III follow-up study is to investigate the benefits and harms of treatment guided by cerebral NIRS monitoring of brain oxygenation in extremely preterm infants during the first 72 hours of life, assessed at two years' corrected age. The hypothesis is that the intervention will decrease a composite of death or moderate-or-severe neurodevelopmental disability at two years' corrected age, and/or increase cognitive function in survivors assessed by the Bayley III/IV test, with insignificant harms. The investigators aim to collect data on as many children as possible and will do this by collecting clinical data from health care records as well as answers from parental questionnaires. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05134116
Study type Observational
Source Rigshospitalet, Denmark
Contact Gorm Greisen, Professor
Phone +45 35 45 50 24
Email gorm.greisen@regionh.dk
Status Recruiting
Phase
Start date September 23, 2021
Completion date October 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03714633 - Stockholm Preterm Interaction-Based Intervention N/A
Not yet recruiting NCT05490173 - The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants N/A
Active, not recruiting NCT04459117 - Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen Phase 2/Phase 3
Completed NCT03649282 - HFNC and NCPAP in Extremely Preterm Infants N/A
Completed NCT01773902 - Protein for Premies N/A
Completed NCT04121897 - Therapist Education and Massage for Parent Infant-Outcomes N/A
Recruiting NCT04413097 - Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants N/A
Recruiting NCT05265195 - PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)
Completed NCT05686252 - RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants N/A
Recruiting NCT06027645 - Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder N/A
Completed NCT04074525 - Evaluating Decisional Regret Among Mothers
Completed NCT05152875 - Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
Completed NCT02782637 - Prenatal Counseling in Extreme Prematurity: Parents' View N/A
Recruiting NCT04715373 - LISA in the Delivery Room for Extremely Preterm Infants N/A
Not yet recruiting NCT05334550 - Effectiveness of Home Based Early Intervention of Extremely Premature Infant by Parent N/A
Not yet recruiting NCT06220461 - Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants N/A
Recruiting NCT05248477 - Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX) N/A
Completed NCT04652063 - Osteopathic Manipulative Medicine to Reduce Developmental Delays N/A
Completed NCT04256889 - Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA N/A
Not yet recruiting NCT03786497 - Protecting Brains and Saving Futures - the PBSF Protocol